[HTML][HTML] Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France

F Gallais, A Velay, C Nazon, MJ Wendling… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We investigated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific
antibodies and T-cell responses against SARS-CoV-2 and human coronavirus (HCoV) 229E …

[HTML][HTML] Refining “Long-COVID” by a prospective multimodal evaluation of patients with long-term symptoms attributed to SARS-CoV-2 infection

M Scherlinger, R Felten, F Gallais, C Nazon… - Infectious diseases and …, 2021 - Springer
… Floriane Gallais, Charlotte Nazon and Samira Fafi-Kremer conducted the virologic evaluations.
Amaury Mengin, Adrien Gas and Pierre Vidailhet participated in the psychiatric evaluation…

Engineering Novel 3D Models to Recreate High‐Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment

…, AS Klymchenko, S Foppolo, C Nazon… - Advanced …, 2022 - Wiley Online Library
Osteosarcoma (OS) is the most common primary bone cancer, where the overall 5‐year
surviving rate is below 20% in resistant forms. Accelerating cures for those poor outcome …

[HTML][HTML] Focus on hypoxia-related pathways in pediatric osteosarcomas and their druggability

…, N Weingertner, S Martin, I Lelong-Rebel, C Nazon… - Cells, 2020 - mdpi.com
Osteosarcoma is the most frequent primary bone tumor diagnosed during adolescence and
young adulthood. It is associated with the worst outcomes in the case of poor response to …

[HTML][HTML] Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas

C Nazon, M Pierrevelcin, T Willaume, B Lhermitte… - Cancers, 2022 - mdpi.com
Simple Summary Radiological and immunohistochemical data were correlated with the
outcome in a retrospective monocentric cohort of 30 pediatric osteosarcomas (OTS). A necrotic …

[HTML][HTML] Coronavirus disease 2019 3 months after hematopoietic stem cell transplant: a pediatric case report

C Nazon, A Velay, M Radosavljevic… - Pediatric Blood & …, 2020 - ncbi.nlm.nih.gov
To the Editor: Pediatric cases represent 1-5% of coronavirus disease 2019 (COVID-19) cases
worldwide. 1 This is linked to the fact that infected children present asymptomatic or pauci-…

[HTML][HTML] Optimizing hydroxyurea treatment for sickle cell disease patients: The pharmacokinetic approach

C Nazon, AN Sabo, G Becker, JM Lessinger… - Journal of clinical …, 2019 - mdpi.com
Background: Hydroxyurea (HU) is a FDA- and EMA-approved drug that earned an important
place in the treatment of patients with severe sickle cell anemia (SCA) by showing its …

Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without Seroconversion (preprint)

F Gallais, A Velay, MJ Wendling, C Nazon, M Partisani… - 2020 - pesquisa.bvsalud.org
Background. In the background of the current COVID-19 pandemic, serological tests are
being used to assess past infection and immunity against SARS-CoV-2. This knowledge is …

Refining “long-COVID” by a prospective multimodal evaluation of patients with long-term symptoms related to SARS-CoV-2 infection

M Scherlinger, R Felten, F Gallais, C Nazon… - medRxiv, 2021 - medrxiv.org
Background COVID-19 long-haulers or “long-COVID” represent 10% of COVID-19 patients
and remain understudied. Methods In this prospective study, we recruited 30 consecutive …

Coronavirus disease 2019 three months after hematopoietic stem cell transplant: a pediatric case report.

C Nazon, A Velay, M RADOSAVLJEVIC… - Authorea …, 2020 - advance.sagepub.com
Pediatric cases represent a small part of COVID-19 cases reported worldwide and children
seem to be mostly asymptomatic. The specific risks for patients in pediatric oncology wards …